James E. Lingeman
Indiana University School of Medicine, Indiana University Health, Methodist Hospital
Papers
7
Total Citations
1,162
H-Index
7
About
James E. Lingeman is a pioneering urologist whose career has been defined by transformative contributions to the surgical management of kidney stones and benign prostatic hyperplasia (BPH). He is best known for his central role in the landmark AUA Guideline on Management of Staghorn Calculi (2005), which has amassed over 913 citations and remains a cornerstone reference for the diagnosis and treatment of complex renal calculi. Lingeman has been a leading advocate for minimally invasive endourology, championing techniques that reduce the need for open surgery, as reflected in his work on the role of open and laparoscopic stone surgery in the modern era. His impact on BPH treatment is equally profound: he has been instrumental in advancing holmium laser enucleation of the prostate (HoLEP) and evaluating novel technologies like Aquablation, with studies on large prostates (80–150 cc) reporting promising 1- and 2-year outcomes. Lingeman’s research also explores the intersection of BPH and prostate cancer surgery, demonstrating the feasibility of robot-assisted radical prostatectomy after HoLEP. With dozens of highly cited papers and a career dedicated to evidence-based innovation, Lingeman has shaped modern urological practice, improving outcomes for countless patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7